Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 761340
Company: SAMSUNG BIOEPIS CO LTD
Company: SAMSUNG BIOEPIS CO LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
EPYSQLI | ECULIZUMAB-AAGH | 300 mg/30 mL (10 mg/mL) | INJECTION;SOLUTION | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
07/19/2024 | ORIG-1 | Approval | N/A |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761340s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761340Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/761340Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/12/2025 | SUPPL-7 | Supplement |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761340Orig1s007ltr.pdf |
01/28/2025 | SUPPL-6 | Supplement |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761340Orig1s006ltr.pdf |
11/15/2024 | SUPPL-3 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761340s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761340Orig1s003ltr.pdf | |
01/21/2025 | SUPPL-2 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761340Orig1s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761340Orig1s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
01/21/2025 | SUPPL-2 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761340Orig1s002lbl.pdf | |
01/21/2025 | SUPPL-2 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761340Orig1s002lbl.pdf | |
11/15/2024 | SUPPL-3 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761340s003lbl.pdf | |
11/15/2024 | SUPPL-3 | REMS | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761340s003lbl.pdf | |
07/19/2024 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761340s000lbl.pdf |